AAO News
The latest clinical breakthroughs, practice management updates, and national advocacy alerts directly from the American Academy of Ophthalmology.
Avedro resubmits FDA application for CXL treatment
Avedro has resubmitted a new drug application for its riboflavin opthalmic solution/KXL system for corneal cross-linking (CXL).
Powered by Steuernachrichten

West Virginia Academy of Eye Physicians and Surgeons — advancing quality eye care through education, advocacy, and community awareness.
About
Resources
Advocacy

























